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Magnetically Controllable Polymer 
Nanotubes from a Cyclized 
Crosslinker for Site-Specific 
Delivery of Doxorubicin
Ben Newland1,2, Daniel Leupelt3, Yu Zheng4, Laurent S. V. Thomas1, Carsten Werner1, 
Martin Steinhart3 & Wenxin Wang5
Externally controlled site specific drug delivery could potentially provide a means of reducing drug 
related side effects whilst maintaining, or perhaps increasing therapeutic efficiency. The aim of this 
work was to develop a nanoscale drug carrier, which could be loaded with an anti-cancer drug and be 
directed by an external magnetic field. Using a single, commercially available monomer and a simple 
one-pot reaction process, a polymer was synthesized and crosslinked within the pores of an anodized 
aluminum oxide template. These polymer nanotubes (PNT) could be functionalized with iron oxide 
nanoparticles for magnetic manipulation, without affecting the large internal pore, or inherent low 
toxicity. Using an external magnetic field the nanotubes could be regionally concentrated, leaving 
areas devoid of nanotubes. Lastly, doxorubicin could be loaded to the PNTs, causing increased 
toxicity towards neuroblastoma cells, rendering a platform technology now ready for adaptation 
with different nanoparticles, degradable pre-polymers, and various therapeutics.
In recent years, there has been a large research focus towards increasing the efficiency of current drugs 
and therapeutics. One method of improving efficiency is through site specific delivery of the drug, 
in order to reduce off-target effects1. Such targeted drug delivery would be particularly beneficial in 
anti-cancer applications where the side effects of a systemic action are problematic. Carbon nanotubes 
(CNTs) have been proposed as one such material for drug delivery2,3. Their small size and bulk produc-
tion capabilities make them a convenient starting material for such biomedical applications, however, 
they hold the inherent drawbacks of toxicity4,5, functionalization requirement6, degradation issues6,7 and 
difficulty internalizing cargo8.
Polymer nanotubes (PNTs) could pose an attractive alternative through the ability to synthesize softer/
weaker materials (where the high strength of CNTs is not required), circumvent the toxicity via the use 
of degradable polymer materials or have larger internal diameters for internal drug loading. Whilst PNT 
synthesis methods such as micropipette stretching techniques can yield hollow polymer nanomaterials9 a 
scalable method such as coating a template could be far more favorable for widespread application. Since 
the early uses of porous anodized aluminum oxide (AAO) as a template material10, much research has 
focused on template production of high aspect ratio materials using a variety of starting components11–15. 
Aside from polymer melt template wetting procedures which require high temperatures (depending on 
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polymer type)12, polymerization within AAO pores usually requires modification of the template with 
a catalyst or initiator, prior to the reaction process13,14. In certain cases specific vinyl containing macro-
monomers have to be pre-synthesized in order for nanotubes to form15. Controlled living polymerization 
techniques such as atom transfer radical polymerization (ATRP) have also been used to synthesize poly-
mer nanotubes but with either the formation of clumped aggregates of tubes (when an AAO template is 
used)14, or pristine tubes are formed which contain residual silica from the sacrificial template16 (a likely 
drawback for biomedical applications).
In this study we aimed to prove a concept that a simple polymerization technique could be used to 
form a photocrosslinkable ethylene glycol dimethacrylate (EGDMA) homopolymer which could be used 
to make PNTs. Furthermore, we aimed to functionalize the nanotubes with iron oxide nanoparticles for 
magnetic manipulation, and show that a large internal pore could be filled with an anticancer drug such 
as doxorubicin. We hypothesized that in situ deactivation enhanced ATRP (DE-ATRP) could produce 
a specific structure of poly(EGDMA) consisting of knots and branches allowing it to photocrosslink 
within AAO pores due to the high percentage of free vinyl groups in its structure. Our objectives were to: 
a) synthesize (and characterize) a homopolymer from a commercially available monomer in large quan-
tities (typically > 5 grams at a time), to prove the scalability of this approach, b) form (and characterize) 
pristine free standing (not aggregated) nanotubes using a single photocrosslinking step, c) demonstrate a 
simple in situ tube functionalization procedure and lastly, d) investigate whether these nanotubes could 
deliver doxorubicin to neuroblastoma in vitro.
Results and Discussion
Nanotube Synthesis and Characterization. Much research into the delivery of therapeutics via 
nanotubes has focused on the use of graphitic carbon nanotubes with subsequent surface functionaliza-
tion to covalently bind a cargo17. Carbon structures containing a nanoscopic open pore (termed carbon 
nanopipes) have been synthesized within an AAO template18–20 but this process requires carbon vapor 
deposition at high temperatures limiting the capacity for in situ functionalization of the tubes. Herein 
we develop a homopolymer designed to be photocrosslinkable within the pores of an AAO template 
and thus allow the formation of hollow nanotubes at room temperature. Figure 1 depicts the “deactiva-
tion enhanced” modification of atom transfer radical polymerization (ATRP) required for the synthesis 
of a homopolymer from the bifunctional vinyl monomer ethylene glycol dimethacrylate (EGDMA)21. 
Traditionally the inclusion of only a few percent of a multi-vinyl monomer in an ATRP co-polymeriza-
tion would result in the formation of an insoluble crosslinked gel22 unsuitable for further study. However, 
recently we have shown that deactivation enhanced ATRP (DE-ATRP) can control the synthesis (reduce 
the kinetic chain length and therefore growth boundary) to such an extent as to allow homopolymeri-
zation of EGDMA into single soluble chains21,23. In this study, we synthesize these chains, which contain 
internal cyclizations (intramolecular crosslinks) and free (unreacted) vinyl groups depicted in Fig.  1 
as overlapping chains (blue circles) and free double bonds sticking out of the chain. However, at later 
reaction stages, as free monomers become more exhausted and cyclized knot chain concentrations are 
high, the cyclized chains combine to form multiple knots joined by intermolecular crosslinks24, shown 
as a green circle in Fig. 1.
Gel permeation chromatography (GPC) analysis during the reaction process (Supplementary 
Information Fig. 1) clearly shows the transition from unimodal peaks of the single chain (1–3 hours), 
to the much broader peaks of the larger, polydisperse, multiple knot structures when chains combine 
(4–5 hours) (Supplementary Fig. 2). 1H NMR spectroscopy (Supplementary Fig. 3) shows the presence 
of unreacted vinyl groups within the polymer structure (78.7%) for subsequent photocrosslinking within 
the AAO template. The final polymer yield was 9.3 g (47% yield).
Figure 2 shows the simple process used to synthesize the nanotubes, whereby the polymer is dissolved 
in a solvent, added to the template surface, and exposed to UV light. Figure 3a shows the “small” tem-
plate, used to synthesize nanotubes of 200 nm diameter and Fig.  3b shows the nanotubes which have 
been released from the template by the addition of NaOH. Figures  3c and 1d show that the diameter 
and length of the nanotubes can be adjusted by varying the pore size of the AAO template used (length 
distributions shown in Fig. 3e). The “small” and “large” templates have pores suitable for the production 
of tubes with diameters of approximately 230 nm and 350 nm respectively as shown in Figs  3f and 1g 
respectively. Many tubes have a curved but regular morphology, with predominantly “open” ends, but 
with the occasional “test tube” like closed end as shown in Fig. 3g. One explanation for the formation of 
hollow tubes instead of solid nanowires is that the template is rapidly wetted by the pre-polymer mix in 
acetone (Supplementary Information Fig. 4), but the acetone evaporates quickly leaving the pre-polymer 
on the pore wall prior to crosslinking. Wall defects are rare (Supplementary Information Fig. 5) but may 
occur where the pore filling results in only a thin layer of polymer. Whilst explaining the difference in 
diameter between the “small” and “large” nanotubes is straightforward (i.e. it is dependent on the pore 
diameter of the template) the reason that the length distributions typically vary is less clear. Perhaps the 
mechanical stability of the smaller nanotubes is lower than that of the large nanotubes due to the greater 
confinement within the smaller pores suppressing the intermolecular entanglements or crosslinks. It was 
therefore desired to analyze if varying the pore depth of the template could alter the length distribution 
of the nanotubes. For this study, a standard deep pore “large” template (100 μ m) was used to synthesize 
nanotubes which were compared with nanotubes produced in a shallow pore “large” template with a 
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depth of 10 μ m. This should, in theory, restrict the maximum nanotube length to 10 μ m. Supplementary 
Information Fig. 6 shows that this restricted pore depth does indeed reduce the length distributions 
with a limited length dependent on the depth of the pore, but does not produce an exact predetermined 
nanotube length. The majority of tubes for either template are between 2–4 μ m in length probably in 
part due to mechanical instability, in-complete template wetting (more layers could be applied in future), 
or breaking during template dissolution. However, since aspect ratio is likely to affect toxicity, this is a 
precise way to set a maximal length of the nanotubes.
Effect of Nanotube Dispersions on Cell Viability. The rationale for developing wide pore, polymer 
based nanotubes, is that they may be more suitable for drug delivery applications than carbon nano-
tubes, via enhanced drug loading and perhaps reduced toxicity. High risk neuroblastoma currently has 
poor prognosis following diagnosis so was chosen as the model system to investigate the use of these 
nanotubes as a drug delivery system. However, to investigate the cytotoxicity of the biomaterial itself (ie. 
nanotubes in their unloaded form), in vitro assessment was carried out using astrocytes: a non-cancerous 
cell type. The cytotoxicity of the nanotubes was measured using the PrestoBlue® assay, after 24 hours 
of incubation of various concentrations of nanotubes on either primary cortical astrocytes (Fig.  4) or 
an astrocyte cell line (Supplementary Information Fig. 9) developed by the Fawcett lab25. These studies 
showed that both sizes of polymer nanotubes retained over 80% astrocyte viability up to a concentration 
of 240 μ g/mL, whereas multi-walled carbon nanotubes (MWNT) of large diameter (170 nm by manu-
facturer’s definition) caused a dose dependent loss in viability. Brightfield images of the nanotube/cell 
incubations (Fig. 4b–d) show that 240 μ g/mL is still a high enough concentration to result in a thick layer 
of nanotubes over the cell and well surface, with large aggregations also visible. The nanotubes them-
selves disperse well in solution (Supplementary Information Fig. 8) as measured by DLS and via visual 
observations over time. Since poly(ethylene glycol) is often used to functionalize materials for reduced 
aggregation, the fact that these tubes are predominantly ethylene glycol based may explain this good 
Figure 1. A simple “one-pot” route to a photocrosslinkable pre-polymer. The homopolymerization of 
EGDMA via in situ Deactivation Enhanced ATRP (DE-ATRP) allows the formation of a growing chain and 
intramolecular cyclizations. In the early reaction phases a knot structured polymer is produced, however, at 
later stages these knots combine via traditional intermolecular branches.
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dispersion. However, the dispersion is concentration dependent as high concentrations such as 4 mg/ml 
will aggregate throughout the day. The difference in cytotoxicity caused by the polymer nanotubes com-
pared to the MWNTs may be due to a number of factors, with the obvious starting point of differing 
material compositions (EGDMA vs graphitic carbon). In addition, the aspect ratio is much smaller for 
the polymer nanotubes, which is likely to explain the reduced toxicity. However, during transmission 
electron microscopy (TEM) analysis an interesting observation made showing the flexible nature of the 
polymer nanotubes. Where an area of the carbon film contained a tear the nanotubes either followed 
the contour of the curling film, or, if they spanned the film tear, they would stretch as the electron beam 
caused a widening of the tear (Supplementary Information Fig. 10). This purely qualitative analysis may 
however give an insight into the reduced toxicity. One could speculatively say that the combination of 
low aspect ratio and nanotube flexibility renders the material less toxic to cells at the concentrations 
analyzed.
Synthesis of Magnetically Controllable Nanotubes. The process of filling the nanotubes with 
ferric oxide (Fe2O3) is depicted in Fig. 5a, where Fe2O3 nanoparticles are added into the polymer solution 
prior to crosslinking. A previous study into the formation of microscale magnetic manipulators used 
electrospinning to form polymer fibers containing superparamagnetic cobalt nanoparticles26. Although 
they demonstrated the connection of hippocampal neurons, the materials produced were micron scale, 
not hollow, and had to be cut into sections with a razor. Here we use an in situ filling mechanism 
that allows tube formation and magnetic functionalization. TEM analysis of the nanoparticles alone 
(Fig.  5b) shows a range of sizes but all are far below the 200 nm pores of the smallest AAO template 
Figure 2. Schematic diagram depicting the facile route to polymer nanotube preparation, via 
photocrosslinking the knot polymers within AAO pores followed by template dissolution in sodium 
hydroxide. 
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used. Nanotubes could be produced which contained Fe2O3 at one end as shown in Fig. 5c–e. However, 
approximately half of the nanotubes appeared not to be functionalized as no nanoparticles could be 
observed at the tube ends. To sort the magnetic nanotubes from the non-magnetic nanotubes, a magnetic 
cell sorter was used (Supplementary Information Fig. 11). In this way, nanotubes containing Fe2O3 were 
attracted to the filter (under the effect of an external magnetic field) whilst the non-functionalized nano-
tubes passed through. After removal of the external magnetic field the functionalized nanotubes could 
be passed into a separate Eppendorf tube. 46% of the nanotubes were functionalized (Supplementary 
Information Fig. 11) and collected for subsequent analysis with Fig. 5f showing three such tubes together. 
Since none of the TEM images of the functionalized tubes either before or after filtration sorting showed 
free nanoparticles it can be assumed that all were incorporated during the photo-crosslinking. Thus 
an approximation of the weight percentage of Fe2O3 per nanotubes can be calculated from the average 
weight of the functionalized nanotube pellet. The value of 2.7 wt% Fe2O3 incorporation can only be taken 
as an approximation across the average of six batches of functionalized nanotubes. Since only about a 
half of the nanotubes was functionalized and only at one end, it would suggest that infiltration of the 
Fe2O3 nanoparticles into the template pores is poor and would have to be further improved if a greater 
weight percentage of Fe2O3 was desired.
Figure 3. Polymer nanotube characterization. SEM images of (a) the 200 μ m AAO template used to 
synthesize the “Small” polymer nanotubes and (b), the nanotubes after dissolution with arrows showing 
open tube ends. The diameter of the nanotubes could be adjusted depending on the template used (c) and 
the nanotubes with a larger diameter were also generally longer in length (d,e). TEM images (f) and (g) 
show “Small” and “Large” diameter nanotubes respectively, whilst (g) also exhibits some closed ends of the 
tubes.
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Doxorubicin Loading and Magnetic Focusing of the Nanotubes. Patients with cancers such as 
glioblastoma multiforme typically suffer extremely poor prognosis, therefore more effective therapies are 
being sought27. Research fields such as nanomedicine seek to improve the delivery efficacy of anti-cancer 
therapeutics by the development of nanoscale drug carriers28. Herein we analyze whether the polymer 
nanotubes can be loaded with a model anticancer drug doxorubicin (preferred for its intrinsic fluores-
cence allowing easy detection of the loaded nanotubes) and whether in vitro delivery can be achieved to 
model human cancer cells SH-SY5Y neuroblastoma.
Dried nanotubes could be filled with a solution of doxorubicin in water by simple re-dispersion in 
the solution. For cytotoxicity experiments a high concentration of doxorubicin loading solution was 
chosen (1.5 mg/mL), however, for specific loading and release analysis a much lower concentration of 
80 μ g/mL was used to allow accurate detection of how much doxorubicin left the loading solution to 
enter the nanotubes. After loading the nanotubes with the doxorubicin solution, the nanotubes were 
centrifuged and washed with PBS extensively to remove any free doxorubicin. Fluorescent microscopy 
imaging (Fig. 6a) showed the doxorubicin loaded nanotubes to have a fluorescent emission at 488 (FITC 
filter) due to the intrinsic fluorescence of doxorubicin, but one cannot distinguish if the doxorubicin is 
within the pore or loaded to the tube wall. Doxorubicin uptake by the nanotubes, could be quantified 
by the change in absorbance of a doxorubicin loading solution at a concentration of 80 μ g/ml, before 
and after the addition of empty nanotubes. An average of 38 ng of doxorubicin was loaded per μ g of 
nanotubes (see Supplementary Table 4), and the release of the drug could be observed over a period of 
8 days (maximum time analyzed) (Supplementary Fig. 12). Although it is unclear what drives such effi-
cient loading (see Supplementary Fig. 12 insert to see how dark red the nanotube pellet becomes), others 
have reasoned that loading to polymers occurs via hydrophobic interaction between the doxorubicin and 
the polymer29. It is interesting to note that the polymers in that study29 were of similar compositions to 
the EGDMA nanotubes in terms of ethylene glycol was the main component, and poly(propylene glycol) 
was used to adjust the hydrophobicity (EGDMA is more hydrophobic than PEG). The sustained release 
profile observed may suggest that the doxorubicin is up-taken within the pore (not just surface loading) 
so that the 1D effect of a single or double open tube end (i.e. low pore surface to internal volume ratio 
- slow release) prolongs the release, as oppose to absorption to the nanotube wall (high surface area to 
volume ratio – quick release).
Doxorubicin loaded nanotubes (both magnetic and non-functionalized) showed anti-cancer activity 
against the human neuroblastoma derived cell line (SH-SY5Y cells, Fig.  6c). Additionally, the MWNT 
toxicity appeared enhanced after exposure to doxorubicin indicating that some doxorubicin may be 
present in the media, or loaded to the MWNT despite three washes (no fluorescence could be detected 
for the MWNT). At a nanotube concentration of 240 μ g/mL neuroblastoma viability could be reduced to 
Figure 4. The polymer nanotubes show far lower cytotoxicity than MWNTs. The viability of primary 
astrocytes (a predominant cell type of the brain) extracted from the newborn rat midbrain is unaffected 
by the incubation with polymer nanotubes (a). Light microscopy analysis shows a heavy coverage of 
the nanotubes on the astrocytes ((b) = MWNT, (c) = “Small” polymer nanotubes, (d) = “Large” polymer 
nanotubes) at the highest concentration analyzed (240 μ g/ml) (scale bars = 100 μ m, n = 4).
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52% (magnetic nanotubes) or 43% (non-functionalized nanotubes), compared to untreated control cells. 
As Fig. 6b shows, this anti-cancer activity is not a function of the toxicity of the nanotubes themselves, 
which show no significant toxicity towards the neuroblastoma even at 240 μ g/mL. For comparison, free 
doxorubicin was incubated with SHSY-5Y cells at a variety of concentrations (see Supplementary Fig. 16) 
showing that the 42% and 52% viability is equivalent to approximately 0.4–0.5 μ g/mL of free doxorubicin.
Another research field which has, of late, received much attention is that of targeted therapies. 
Designing targeted drug delivery systems can involve the targeting of the delivery vector to the target 
organ (for instance crossing the blood brain barrier to the brain), or to the specific cell, or a combination 
of both. This study aimed to make nanotubes that could be controlled/targeted via an external magnetic 
field. However, in principle the polymerization strategy could allow further modification of the polymer 
surface with antibody fragments or cell penetrating peptides via the free vinyl groups within the polymer 
structure (Supplementary Information Fig. 7 and Supplementary Table 3). The inclusion of iron oxide 
nanoparticles in material constructs can allow visualization of the carrier28, or magnetic manipulation18 
or controlled drug release30. A recent study showed that ferrofluid (Fe3O4) could be added to carbon 
nanotubes formed by chemical vapor deposition within an AAO template18 (previously termed carbon 
nanopipes19,20). Herein by contrast, iron oxide nanoparticles were used to functionalize the nanotube 
walls via an in situ method without filling the pore space required for drug loading. It should be noted 
here, that although by the method described herein ~50% of the nanotubes were functionalized with the 
iron oxide nanoparticles, it is unclear to the authors how a greater filling can be achieved. Increasing the 
concentration of the nanoparticles, or adding the nanoparticles directly to the polymer solution prior 
Figure 5. Schematic depiction ((a,c) insert) of functionalizing the nanotubes with magnetite. TEM 
images of: (b) magnetite nanoparticles, (c) a functionalized nanotube with a magnetic end, (d,e) sample 
images of magnetic nanotubes before magnetic filter separation and, (f) magnetically functionalized 
nanotubes after purification.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:17478 | DOI: 10.1038/srep17478
to crosslinking showed no increase in loading efficiency. However, the method of magnetically sorting 
the nanotubes allowed subsequent experiments to be performed with pure solutions of functionalized 
nanotubes.
Non-functionalized nanotubes typically show an even spread across the cell monolayer (Supplementary 
Information Fig. 13). Functionalized nanotubes also show this even spread in the absence of an external 
magnetic field (Fig. 7a); however, the placement of the well plate upon a magnetic stirrer begins to drive 
the nanotubes in the direction determined by the magnetic field (see Supplementary Information Video 1). 
The nanotubes collect over at one side of the well plate (Fig. 7b,c, and Supplementary Information Fig. 14), 
which, despite an initial even covering, results in the opposite side of the well being completely devoid of 
nanotubes. These experiments highlight the ability of these nanotubes to be targeted to specific regions of 
cells in vitro, showing that the toxic effects of the doxorubicin can be localized instead of spread through-
out the well. Finally, we show that doxorubicin released from non-functionalized and functionalized 
doxorubicin loaded nanotubes can be up-taken by the neuroblastoma cells by fluorescent microscopy 
without the up-take of the nanotubes themselves (Fig. 8 and Supplementary Information Fig. 15). At the 
highest concentration (240 μ g/mL) most cells were shown to have up-taken doxorubicin as green fluo-
rescence can be seen co-localizing with the cell regions shown by the brightfield images. However, at this 
concentration, empty nanotubes fluorescently labelled with fluorescein could be observed in the vicinity 
of the cells, but not within the lysosomes (indicated by LysoTracker® Deep Red, Life Technologies). This 
important finding indicates that the polymer nanotubes can act as a nanoscale carrier to deliver doxoru-
bicin to cells without cell uptake or associated complications.
In conclusion a simple modification of atom transfer radical polymerization is used to make a pho-
tocrosslinkable polymer. A solution of this polymer can be crosslinked within the pores of an AAO 
template either in the presence or absence of iron oxide nanoparticles. The polymer nanotubes tubes 
released by dissolving the AAO template can be filled with doxorubicin, can cause dose dependent tox-
icity (otherwise absent if doxorubicin is absent) and can be magnetically directed to one side of the 
well plate to target doxorubicin delivery in vitro. This simple platform technology allows a wide range 
of further investigations such as functionalization with super paramagnetic iron oxide nanoparticles, or 
gold nanorods for combined hyperthermia and drug delivery applications.
Methods
Materials. Ethylene glycol dimethacrylate (EGDMA) (Aldrich) was used as the monomer, and ethyl 
2-bromoisobutyrate (EBriB, 98%, Aldrich) was used as the initiator. The ligand pentamethyldiethylen-
etriamine (PMDETA, 99%, Aldrich), the catalyst copper(II) chloride (CuCl2, 97%, Aldrich), the reduc-
ing agent L-ascorbic acid (AA, 99%, Aldrich), and solvent 2-Butanone (HPLC grade, Aldrich), were all 
Figure 6. Nanotubes can be loaded with doxorubicin to mediate neuroblastoma cell death. High 
power (100× lens and 4× optical zoom) brightfield ((a) left) and fluorescent ((a) middle) microscopy of 
doxorubicin loaded nanotubes, visible via the intrinsic fluorescence of doxorubicin (emission at 488 nm: 
overlay (a) right). Both magnetic and non-magnetic nanotubes show no cytotoxicity towards SHSY5Y 
neuroblastoma at all concentrations tested (b), but cause over 40% loss in viability when incubated for 
24 hours with doxorubicin prior to cell treatment (c) (n = 4, scale bars = 5 μ m).
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used as received. For polymer purification and analysis n-hexane (ACS reagent grade, Aldrich), dichlo-
romethane (ACS reagent grade, Aldrich) and d-Chloroform (99.8%, Aldrich) were used as received. 
For nanotube synthesis either self-ordered AAO templates prepared according to procedures reported 
previously31,32 or Whatman™ Anodisc™ filter membranes (0.2 μ m pore, Fischer Scientific) were used.
Polymer Synthesis. Homopolymerization of EGDMA was carried out via the deactivation enhanced 
ATRP strategy outlined previously21. The initiator (ethyl 2-bromoisobutyrate (EBriB)) to monomer 
(ethylene glycol dimethacrylate (EGDMA)) ratio was 1:50. Table 1 in the Supplementary Information 
shows the ratio of all the reaction components along with the corresponding mass used. Firstly EGDMA 
(100 mmol) was weighed out into a clean two neck round bottomed flask, then the ligand (pentam-
ethyldiethylenetriamine (PMDETA) 0.25 mmol) was added along with the catalyst (copper chloride 
(CuCl2, 0.25 mmol). EBriB was then added (2 mmol) along with the solvent butanone (50 mL) and the 
flask was de-gassed by bubbling nitrogen gently through the liquid. After 20 minutes the reaction was 
started by adding the reducing agent ascorbic acid (0.05 mmol) in a 100 mg/ml water solution carefully 
into the flask. Small samples (0.5 mL) were removed every hour to monitor the reaction progress by gel 
permeation chromatography (GPC) and the reaction was allowed to continue until very broad peaks 
were observed (multi-knot polymer24) (Supplementary Information Fig. 1). The experiment was stopped 
by opening the flask and exposing the catalyst to air. This was then diluted with butanone and passed 
through a column of alumina for chromatography and dripped into a large excess of hexane to remove 
Figure 7. Magnetically controlled nanotubes can be directed within a well plate. Light microscope images 
of doxorubicin loaded magnetically functionalized nanotube clusters, which, in the absence of an external 
magnetic field spread evenly across a well plate (a). In contrast, doxorubicin loaded magnetic nanotubes can 
be guided away from one side of the well (upper image of (b)) towards the opposite side of the same well 
(lower image of (b). This could be repeated in different directions ((c) and SI Figure S14) depending on the 
placement of the external magnetic field (example images from 6 replicates, scale bars = 200 μ m).
www.nature.com/scientificreports/
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Figure 8. Doxorubicin loaded magnetic nanotubes achieve cell death without the uptake of the 
nanotubes themselves. Light and fluorescent microscopy images of SHSY-5Y cells incubated for 2 hours 
(a) or 24 hours (b) with doxorubicin loaded nanotubes at a concentration of 240 μ g/mL (b). The intrinsic 
fluorescence of doxorubicin could be observed in the nanotubes at a wavelength of 488 nm and overlaid 
with bright field images merged with DAPI nuclear stain (right hand images) to show that many cells are 
affected by the doxorubicin loaded nanotubes after a 24 hour incubation period. A separate experiment 
was performed (c) with fluorescein labeled nanotubes (green) containing no doxorubicin, where cells were 
labelled with the DAPI nuclear stain and the lysosome tracker (LysoTracker® Deep Red), showing that 
despite nanotubes residing in the vicinity of the cells, no cell uptake of the nanotubes can be observed.
www.nature.com/scientificreports/
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the free monomer. The precipitated polymer was then filtered through filter paper under vacuum and 
allowed to dry. The yield was obtained by gravimetric analysis.
Determination of Molecular Weight by GPC. The small samples taken from the reaction vessel 
were diluted in DMF and filtered through aluminia for chromatography before analysis. The molecular 
weight and molecular weight distribution of each sample was determined using a Varian 920-LC instru-
ment with a refractive index detector (RI) calibrated with linear polystyrene standards. Chromatograms 
were run at 50 °C using DMF as eluent with a flow rate of 1 ml/min.
Nuclear magnetic resonance (NMR) spectroscopy. The polymer composition was assessed by 
1H NMR spectroscopy, by dissolving the purified polymer in deuterated chloroform and reporting all 
chemical shifts in ppm relative to TMS. SI Equation 1 was used to determine the percentage of polymer 
composition.
Synthesis of Polymer Nanotubes. 5 μ L of poly(EGDMA) (5% w/v in acetone) was added to the top 
of an AAO template and spread carefully with the pipette tip. The template was then flushed with nitrogen 
and exposed to UV light for 10 minutes (Linos, Delolux 04, λ = 315–500 nm, intensity 8000 mW/cm2) 
to crosslink the polymer within the template pores. To obtain free standing nanotubes the AAO tem-
plate was submerged in 1.5 mL of NaOH (1 M) for 15 minutes and briefly sonicated in a sonication bath 
without any prior template polishing. Purification of the nanotubes was performed by transferring the 
nanotube/NaOH mix to an Eppendorf tube and centrifuging for 10 minutes at 13,000 rpm. The super-
natant was removed and the replaced with water, then the process was repeated twice with ethanol. To 
obtain a dry weight for subsequent study, the Eppendorf was first weighted then re-weighed after the 
ethanol had evaporated in under laminar flow. Fluorescently labelled nanotubes for cell up-take analysis 
were performed as above but with the inclusion of 2.5 wt% of fluorescein co-acrylate (Sigma) prior to 
UV crosslinking within the template.
Synthesis of Magnetically Controllable Nanotubes. 5 μ l of 1.5 mg/mL magnetite (Fe2O3 nanop-
owder – Sigma) in DMF was first added to the AAO template and subjected to sonication, then 5 μ L of 
poly(EGDMA) (10% w/v in acetone) was added on top. The magnetic nanotubes were removed from 
the template and purified as outlined above. To separate magnetic nanotubes from non-magnetic nano-
tubes, the MACS miltenyi biotec equipment was used (see Supplementary Information Fig. 6) which is 
normally used to magnetically sort cells. The column was first washed with deionized water, then 1 mL 
of nanotube suspension was added and passed through the column. Non-magnetic nanotubes were col-
lected underneath in an Eppendorf tube, and one water wash was performed to ensure all non-magnetic 
nanotubes had passed through. Then the column was removed from the magnet and a further 1 mL of 
water was added and pushed through into a separate Eppendorf to flush out the magnetic nanotubes. 
These were then washed twice with ethanol and allowed to dry as described above.
Characterization of Nanotubes. Samples were prepared for scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM) by dropping 10 μ l or 5 μ l of a nanotube suspension (in 
ethanol) onto an SEM stub or carbon TEM grid respectively. Once fully dry, the sample for SEM was 
gold coated (SCD 050, BAL-TEC) for 60 seconds, and imaged using a Philips Environmental SEM (XL30) 
but in SEM mode. TEM images were obtained using a Zeiss Libra 200 TEM with an accelerating volt-
age of 200 kV using the contrast aperture when necessary. Length and diameter measurements were 
made using ImageJ software. Five dynamic light scattering (DLS) experiments were performed using a 
DynaPro NanoStar photospectrometer (WYATT Technology Corporation, USA), with nanotubes at a 
concentration of 1 mg/ml in PBS.
Raman spectroscopy analysis of the pre-polymer and nanotubes was performed using the Confocal 
Raman Microscope alpha 300 R (WITec GmbH, Ulm, Germany) equipped with a laser with an excitation 
wavelength of 785 nm and a laser power of 500 μ W. Samples were measured with a 20× objective and 
an integration time of 0.5 s for a single scan in the wavelength region from 200 to 1800 cm− 1. For each 
spectrum 200 accumulations were performed.
Cell Culture. Primary cortical astrocytes were extracted from newborn rat pups (day 3) by a com-
bination of two protocols33,34 as reported previously35. Both primary astrocytes and SHSY-5Y (Sigma) 
neuroblastoma cells were cultured in 50% Dulbecco’s Modified Eagles Medium (DMEM) as a 1:1 mix 
with F12 Ham (Gibco), 10% filtered fetal bovine serum (FBS) (Gibco) and 1% Penicillin/Streptomycin 
(P/S) (Gibco) at 37 °C with 5% CO2 using standard cell culturing techniques.
Doxorubicin Loading and Release. Doxorubicin (LC Laboratories) was dissolved in deionized 
water to a final concentration of 1.5 mg/mL. The dried pellet of nanotubes were simply re-suspended 
in the doxorubicin solution and left at room temperature overnight. The tubes were then washed three 
times by centrifugation (13,000 rpm), supernatant removal, and re-suspension in sterile PBS. After the 
final wash, the nanotubes were re-suspended in the cell culture media described above. Loaded nano-
tubes were visualized using a confocal laser scanning microscope in both brightfield mode and with the 
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FITC filter, using a 100× lens and 4× digital zoom. Unloaded nanotubes were used as a comparison 
(data not shown) to check for the possibility of nanotube auto fluorescence (none observed). For specific 
loading and release analysis, a lower concentration of doxorubicin (80 μ g/ml) was used to calculate the 
percentage of the loading solution entered the nanotubes without absorbance maxima being reached. 
263 μ g of the nanotubes were incubated in 200 μ l of doxorubicin and incubated at 37 °C for 48 hours, 
before being removed by centrifugation and washed. The absorbance of the loading solution, was meas-
ured before and after incubation to determine the amount loaded to the nanotubes. The nanotubes were 
then washed in PBS, before fresh PBS was added for a release study over a period of one week (at 37 °C), 
with samples being taken for analysis at certain time points which included a total replacement of the 
PBS so as to allow the calculation of cumulative release. Experiments were performed in triplicate and 
average values were calculated.
Cytotoxicity Analysis. Cells were plated in a 96 well plate at a density of 10,000 cells per well 24 hours 
prior to experimentation. A stock solution of the nanotubes was made up in media and sonicated briefly 
immediately before performing the serial dilutions (240 μ g/mL down to 30 μ g/mL). The media in each 
well was removed and replaced either with 100 μ L the nanotubes at the variety of concentrations, or 
100 μ L of media alone for the negative control. After 24 hours, the cells were imaged using a light micro-
scope and then washed two times with PBS. A 10% solution of PrestoBlue® in media was added to each 
well and incubated either for 1 hour (astrocytes) or 30 minutes (SHSY-5Y cells) until the color change 
from blue to pink could be observed in the control wells. The fluorescence was read with a plate reader at 
an excitation wavelength of 540 nm and an emission wavelength of 590 nm, and changes in fluorescence 
were normalized to control wells reported as 100% viable. In addition, CLSM was used to assess the 
uptake of doxorubicin loaded nanotubes in neuroblastoma cells at two different nanotube concentrations 
(30 μ g/mL and 240 μ g/mL). A 20× lens was used to image clusters of nanotubes within SHSY-5Y cells, 
via an overlay of FITC filter (doxorubicin) and brightfield images.
Magnetic Focusing of Nanotubes. For these experiments the well plate set up was the same as 
described above except that the well plate was placed on top of a magnetic stir plate (placed within the 
cell culture incubator) for the duration of the incubation period (24 hours). Prior to the study, a 96 well 
plate containing small stir bars was placed at a specific point where the direction of nanotube movement 
could be predicted within the well. The stirring speed was set to a slow 100 rpm to assist the movement of 
the nanotubes. After the incubation period, the well plate was removed from the stir plate and observed 
by light microscopy.
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